We carry it because the science supports it, and because our patients see measurable results when it's used consistently
Pro: Limited studies have suggested that it's more effective than other methods, other than IV, with fewer side effects
A review team from Poland, for example, suggested that future studies should focus on identifying possible side effects
Data specific to the combined use of these two peptides is limited, and any such research should be treated as exploratory
Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
doi: 10.3389/fmolb.2024.1440187